Skip to main content

ADVERTISEMENT

Jolynn Tumolo

News
02/14/2024
Jolynn Tumolo
Sterility concerns due to unsanitary manufacturing conditions have prompted the US Food and Drug Administration (FDA) to issue a Class I designation for a recall spanning 27 over-the-counter eye drops sold by various retailers throughout the...
Sterility concerns due to unsanitary manufacturing conditions have prompted the US Food and Drug Administration (FDA) to issue a Class I designation for a recall spanning 27 over-the-counter eye drops sold by various retailers throughout the...
Sterility concerns due to...
02/14/2024
Pharmacy Learning Network
News
02/13/2024
Jolynn Tumolo
Intravenous allogeneic stem cell therapy within 18 to 36 hours of ischemic stroke onset was safe but did not improve short-term outcomes compared with placebo, according to study results from a phase 2/3 trial published in JAMA Neurology.
Intravenous allogeneic stem cell therapy within 18 to 36 hours of ischemic stroke onset was safe but did not improve short-term outcomes compared with placebo, according to study results from a phase 2/3 trial published in JAMA Neurology.
Intravenous allogeneic stem cell...
02/13/2024
Neurology
News
02/09/2024
Jolynn Tumolo
The US Food and Drug Administration (FDA) has issued a Class I designation for the recall of more than 41,000 bags of intravenous (IV) phenylephrine hydrochloride from Leiters Health, according to the February 7, 2024, FDA Enforcement Report....
The US Food and Drug Administration (FDA) has issued a Class I designation for the recall of more than 41,000 bags of intravenous (IV) phenylephrine hydrochloride from Leiters Health, according to the February 7, 2024, FDA Enforcement Report....
The US Food and Drug...
02/09/2024
Pharmacy Learning Network
News
02/09/2024
Jolynn Tumolo
An equipment malfunction that may have led to drug superpotency has prompted Denver Solutions, which does business as Leiters Health, to recall approximately 17,000 bags of intravenous (IV) vancomycin hydrochloride, according to the February...
An equipment malfunction that may have led to drug superpotency has prompted Denver Solutions, which does business as Leiters Health, to recall approximately 17,000 bags of intravenous (IV) vancomycin hydrochloride, according to the February...
An equipment malfunction that...
02/09/2024
Pharmacy Learning Network
a young boy looks sad
News
02/09/2024
Jolynn Tumolo
Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) and psychiatric comorbidities had a 2-fold higher risk of a subsequent schizophrenia diagnosis compared with those with ADHD and no comorbidities.
Children and adolescents with attention-deficit/hyperactivity disorder (ADHD) and psychiatric comorbidities had a 2-fold higher risk of a subsequent schizophrenia diagnosis compared with those with ADHD and no comorbidities.
Children and adolescents with...
02/09/2024
Psych Congress Network
News
02/08/2024
Jolynn Tumolo
The Million Veteran Program (MVP) enrolled its one-millionth veteran in November 2023, making it the largest, most diverse genetic research program within a health care system in the world.
The Million Veteran Program (MVP) enrolled its one-millionth veteran in November 2023, making it the largest, most diverse genetic research program within a health care system in the world.
The Million Veteran Program...
02/08/2024
Veterans Health Today
News
02/08/2024
Jolynn Tumolo
Nearly 23,000 bags of intravenous (IV) fentanyl citrate from Leiters Health are under a Class I recall for potential superpotency. According to the February 7, 2024, US Food and Drug Administration (FDA) Enforcement Report, the IV bags may...
Nearly 23,000 bags of intravenous (IV) fentanyl citrate from Leiters Health are under a Class I recall for potential superpotency. According to the February 7, 2024, US Food and Drug Administration (FDA) Enforcement Report, the IV bags may...
Nearly 23,000 bags of...
02/08/2024
Pharmacy Learning Network
A doctor examines MRI scans of a brain.
News
02/07/2024
Jolynn Tumolo
After promising findings in a small, open-label, phase 1 pilot study of low-dose interleukine-2 (IL-2) immunotherapy in patients with Alzheimer disease (AD), researchers are proceeding with a double-blinded, randomized, placebo-controlled,...
After promising findings in a small, open-label, phase 1 pilot study of low-dose interleukine-2 (IL-2) immunotherapy in patients with Alzheimer disease (AD), researchers are proceeding with a double-blinded, randomized, placebo-controlled,...
After promising findings in a...
02/07/2024
Neurology
Bipolar Disorder Increases Mortality Risk More Than Smoking
News
02/05/2024
Jolynn Tumolo
A diagnosis of bipolar disorder increased the risk of premature death more than smoking or being older than 60 years, according to study results published in Psychiatry Research.  
A diagnosis of bipolar disorder increased the risk of premature death more than smoking or being older than 60 years, according to study results published in Psychiatry Research.  
A diagnosis of bipolar disorder...
02/05/2024
Psych Congress Network
02/05/2024
Jolynn Tumolo
The Nebraska chapter of the Alzheimer’s Association has introduced a bill in the state legislature that specifies the type of training direct care staff must receive to work with patients with Alzheimer disease, dementia, and related...
The Nebraska chapter of the Alzheimer’s Association has introduced a bill in the state legislature that specifies the type of training direct care staff must receive to work with patients with Alzheimer disease, dementia, and related...
The Nebraska chapter of the...
02/05/2024
Annals of Long-Term Care